Market Overview:
The global androgen and anabolic steroid market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and growing demand for testosterone replacement therapy (TRT). Testosterone is the most commonly prescribed drug for TRT. The use of testosterone replacement therapy is increasing due to the growing awareness about its benefits among men. Moreover, rising incidence of infertility is also propelling the demand for androgenic steroids in hospitals and pharmacies. However, stringent regulations by regulatory authorities are restraining the growth of this market. The global androgenic steroids market has been segmented on the basis of type into testosterone, methyltestosterone, fluoxymesterone, and others. On the basis of application, it has been segmented into hospitals, pharmacies,,and others). Geographically,,the global market has been divided into North America,,Latin America,,Europe,,,,Asia Pacific,,,,and Middle East & Africa,. In terms with geography,.North America accounted for majority share in 2017 owing to high prevalence rateof chronic diseases such as obesity,.diabetes mellitus.,and heart disease.,Furthermore,.the region offers lucrative opportunities due tobusiness-friendly environment coupled with technological advancements. Asia Pacific is projectedto witness highest CAGR during forecast period owingto rapidly changing lifestyle coupled with increasing disposable incomeamong consumers.
Product Definition:
Androgen: a hormone that stimulates the development and maintenance of masculine characteristics.
Anabolic steroid: a synthetic drug related to the male sex hormone testosterone, used in medicine to promote muscle growth.
Testosterone:
Testosterone is the main hormone for Androgen and Anabolic Steroid (AS) production in the human body. It is responsible for growth, development, and maintenance of masculine characteristics such as strength, muscle mass, voice change & sexual function. Testosterone also has a significant impact on other hormones that regulate functions such as insulin secretion & glucagon release which are crucial to athletic performance enhancement.
Methyltestosterone:
Methyltestosterone is an injectable androgenic hormone with a weak agonist effect at the level of the Androgen Receptor (AR). It was first introduced as a prescription drug under the brand name “ulet” by Eli Lilly & Company in 1960. The drug has been used extensively for treatment of gynecomastia, which is characterized by excessive growth of female hormones ( estrogen and progesterone) in males.
Application Insights:
The others application segment includes deca, nandrolone, androstenedione, and trenbolone. The global market for these compounds is dominated by North America with a revenue share of over 60% in 2017. Factors such as the presence of major pharmaceutical companies that manufacture androgenic products; high prevalence of male pattern baldness (androgenetic alopecia) which drives demand for AndroGel; rising awareness about health & wellness among the young population are some of the key factors driving this segment.
On the other hand Europe is estimated to be fastest growing region with a CAGR around 11% from 2018 to 2030 owing to increasing healthcare spending in countries like Germany and France along with well-established healthcare infrastructure driven by factors such as aging population will drive this industry growth over next few years.
Regional Analysis:
North America dominated the global market in terms of revenue in 2017. The growth can be attributed to rising incidence of diseases such as prostate cancer, obesity, and cardiovascular disorders among others. Moreover, increasing use of AndroGel by athletes is also expected to drive the regional market over the forecast period. Asia Pacific is expected to witness significant growth during the forecast period owing to growing geriatric population and rising prevalence of chronic diseases such as diabetes and osteoporosis that are associated with low testosterone levels.
Growth Factors:
- Increasing awareness about the benefits of androgen and anabolic steroids among athletes and bodybuilders.
- Growing demand for muscle-building supplements among the young population.
- Rising incidence of sports injuries that can be treated with androgen and anabolic steroids.
- Increasing use of these drugs for medical purposes such as treating delayed puberty, osteoporosis, etc.
- Technological advancements in the manufacturing of androgen and anabolic steroids that make them more effective and safer to use
Scope Of The Report
Report Attributes
Report Details
Report Title
Androgen and Anabolic Steroid Market Research Report
By Type
Testosterone, Methyltestosterone, Fluoxymesterone, Others
By Application
Hospitals, Pharmacy, Others
By Companies
Auxilium Pharmaceuticals, AbbVie, Teva, GlaxoSmithKline, Endo Pharmaceuticals, Pfizer, Acerus Pharmaceuticals, Antares Pharma, Amneal Pharmaceuticals, Solvay Pharmaceuticals, Bausch Health, Pharmacia and Upjohn, Upsher-Smith, Clarus Therapeutics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
150
Number of Tables & Figures
105
Customization Available
Yes, the report can be customized as per your need.
Global Androgen and Anabolic Steroid Market Report Segments:
The global Androgen and Anabolic Steroid market is segmented on the basis of:
Types
Testosterone, Methyltestosterone, Fluoxymesterone, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Pharmacy, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Auxilium Pharmaceuticals
- AbbVie
- Teva
- GlaxoSmithKline
- Endo Pharmaceuticals
- Pfizer
- Acerus Pharmaceuticals
- Antares Pharma
- Amneal Pharmaceuticals
- Solvay Pharmaceuticals
- Bausch Health
- Pharmacia and Upjohn
- Upsher-Smith
- Clarus Therapeutics
Highlights of The Androgen and Anabolic Steroid Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Testosterone
- Methyltestosterone
- Fluoxymesterone
- Others
- By Application:
- Hospitals
- Pharmacy
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Androgen and Anabolic Steroid Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Androgen and anabolic steroid are terms used to describe a group of hormones that work together to stimulate the growth of muscle tissue. Androgens are testosterone-like hormones, while anabolic steroids are synthetic versions of these same hormones.
Some of the major players in the androgen and anabolic steroid market are Auxilium Pharmaceuticals, AbbVie, Teva, GlaxoSmithKline, Endo Pharmaceuticals, Pfizer, Acerus Pharmaceuticals, Antares Pharma, Amneal Pharmaceuticals, Solvay Pharmaceuticals, Bausch Health, Pharmacia and Upjohn, Upsher-Smith, Clarus Therapeutics.
The androgen and anabolic steroid market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Androgen and Anabolic Steroid Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Androgen and Anabolic Steroid Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Androgen and Anabolic Steroid Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Androgen and Anabolic Steroid Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Androgen and Anabolic Steroid Market Size & Forecast, 2018-2028
4.5.1 Androgen and Anabolic Steroid Market Size and Y-o-Y Growth
4.5.2 Androgen and Anabolic Steroid Market Absolute $ Opportunity
Chapter 5 Global Androgen and Anabolic Steroid Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Androgen and Anabolic Steroid Market Size Forecast by Type
5.2.1 Testosterone
5.2.2 Methyltestosterone
5.2.3 Fluoxymesterone
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Androgen and Anabolic Steroid Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Androgen and Anabolic Steroid Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Pharmacy
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Androgen and Anabolic Steroid Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Androgen and Anabolic Steroid Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Androgen and Anabolic Steroid Analysis and Forecast
9.1 Introduction
9.2 North America Androgen and Anabolic Steroid Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Androgen and Anabolic Steroid Market Size Forecast by Type
9.6.1 Testosterone
9.6.2 Methyltestosterone
9.6.3 Fluoxymesterone
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Androgen and Anabolic Steroid Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Pharmacy
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Androgen and Anabolic Steroid Analysis and Forecast
10.1 Introduction
10.2 Europe Androgen and Anabolic Steroid Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Androgen and Anabolic Steroid Market Size Forecast by Type
10.6.1 Testosterone
10.6.2 Methyltestosterone
10.6.3 Fluoxymesterone
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Androgen and Anabolic Steroid Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Pharmacy
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Androgen and Anabolic Steroid Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Androgen and Anabolic Steroid Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Androgen and Anabolic Steroid Market Size Forecast by Type
11.6.1 Testosterone
11.6.2 Methyltestosterone
11.6.3 Fluoxymesterone
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Androgen and Anabolic Steroid Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Pharmacy
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Androgen and Anabolic Steroid Analysis and Forecast
12.1 Introduction
12.2 Latin America Androgen and Anabolic Steroid Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Androgen and Anabolic Steroid Market Size Forecast by Type
12.6.1 Testosterone
12.6.2 Methyltestosterone
12.6.3 Fluoxymesterone
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Androgen and Anabolic Steroid Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Pharmacy
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Androgen and Anabolic Steroid Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Androgen and Anabolic Steroid Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Androgen and Anabolic Steroid Market Size Forecast by Type
13.6.1 Testosterone
13.6.2 Methyltestosterone
13.6.3 Fluoxymesterone
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Androgen and Anabolic Steroid Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Pharmacy
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Androgen and Anabolic Steroid Market: Competitive Dashboard
14.2 Global Androgen and Anabolic Steroid Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Auxilium Pharmaceuticals
14.3.2 AbbVie
14.3.3 Teva
14.3.4 GlaxoSmithKline
14.3.5 Endo Pharmaceuticals
14.3.6 Pfizer
14.3.7 Acerus Pharmaceuticals
14.3.8 Antares Pharma
14.3.9 Amneal Pharmaceuticals
14.3.10 Solvay Pharmaceuticals
14.3.11 Bausch Health
14.3.12 Pharmacia and Upjohn
14.3.13 Upsher-Smith
14.3.14 Clarus Therapeutics
